Status:
UNKNOWN
Assessment and Treatment of Loiasis With Positive Microfilaremia
Lead Sponsor:
University Hospital, Angers
Conditions:
Loiasis With Positive Blood Microfilaremia
Eligibility:
All Genders
Brief Summary
Loiasis is a vector-borne filariasis endemic in the forested areas in Central Africa whose incidence and morbi-mortality are poorly understood. Estimated prevalence is around 10 millions cases for a p...
Detailed Description
The protocol is based on the inclusion of patients diagnosed with loiasis with at least one positive blood microfilaremia \> 0mf/ml between the 01/01/2000 and the 12/31/2022. Other inclusion criteria ...
Eligibility Criteria
Inclusion
- Patient managed in one of the participating centers between the 01/01/2000 and the 12/31/2022
- Loiasis diagnosis with at least one positive blood microfilaremia \> 0mf/ml
- Patient treated against loiasis
- At least one clinical and/or biological assessment after the first treatment dose
Exclusion
- \- Patients not fulfilling inclusion criteria
Key Trial Info
Start Date :
February 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06194149
Start Date
February 1 2024
End Date
June 30 2024
Last Update
January 8 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.